Merck (NYSE: MRK) is a top pharmaceutical company coming off a good quarter that shows it is growing its top and bottom lines. Even with that growth, the stock still trades at a fairly modest ...

It is hard to get excited after looking at Merck's (NYSE:MRK) recent performance, when its stock has declined 5.6% over the past three months. But if you pay close attention, you might find that ...

Merck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Merck’s Ebola vaccine offered substantial protection to people vaccinated during the 2018-2020 outbreak in the Democratic Republic of the Congo, with an effectiveness of 84% in those who had ...

MANILA, Philippines — The rollout of free online medical consultation for yellow card holders in Makati City began on Monday. Makati City Mayor Abby Binay said the KonsultaMD app service covers ...

The Merck Manuals Online Medical Library Clinical Pharmacology Section: provides a general review of pharmacokinetic parameters: absorption, bioavailability, distribution, excretion and metabolism ...